| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,400 | 5,650 | 02.04. |
Zu dieser Aktie sind derzeit keine Informationen verfügbar.
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
Keine Umsätze verfügbar. | ||
| Tagesumsatz Xetra | 0,000 0,00 % | 0 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | 4BaseBio expands facilities to support growing synthetic DNA demand | 4 | Alliance News | ||
| Di | 4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK | 117 | GlobeNewswire (Europe) | 4basebio PLC ("4basebio" or the "Company") Cambridge, UK, 31 March 2026 - 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces... ► Artikel lesen | |
| Di | 4basebio Plc - Lease of Manufacturing Facility | 292 | PR Newswire | 4basebio Plc - Lease of Manufacturing Facility
PR Newswire
LONDON, United Kingdom, March 31
4basebio... ► Artikel lesen | |
| 4BASEBIO Aktie jetzt für 0€ handeln | |||||
| 12.03. | IN BRIEF: 4basebio appoints Scott Lorimer as chief operating officer | 5 | Alliance News | ||
| 12.03. | 4basebio Plc - Appointment of COO | 365 | PR Newswire | 4basebio Plc - Appointment of COO
PR Newswire
LONDON, United Kingdom, March 12
THIS... ► Artikel lesen |